These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26302439)

  • 1. Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease.
    Tuszynski MH; Yang JH; Barba D; U HS; Bakay RA; Pay MM; Masliah E; Conner JM; Kobalka P; Roy S; Nagahara AH
    JAMA Neurol; 2015 Oct; 72(10):1139-47. PubMed ID: 26302439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons.
    Tuszynski MH
    Cell Transplant; 2000; 9(5):629-36. PubMed ID: 11144960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.
    Rafii MS; Tuszynski MH; Thomas RG; Barba D; Brewer JB; Rissman RA; Siffert J; Aisen PS;
    JAMA Neurol; 2018 Jul; 75(7):834-841. PubMed ID: 29582053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery.
    Castle MJ; Baltanás FC; Kovacs I; Nagahara AH; Barba D; Tuszynski MH
    Hum Gene Ther; 2020 Apr; 31(7-8):415-422. PubMed ID: 32126838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
    Rafii MS; Baumann TL; Bakay RA; Ostrove JM; Siffert J; Fleisher AS; Herzog CD; Barba D; Pay M; Salmon DP; Chu Y; Kordower JH; Bishop K; Keator D; Potkin S; Bartus RT
    Alzheimers Dement; 2014 Sep; 10(5):571-81. PubMed ID: 24411134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery.
    Nagahara AH; Bernot T; Moseanko R; Brignolo L; Blesch A; Conner JM; Ramirez A; Gasmi M; Tuszynski MH
    Exp Neurol; 2009 Jan; 215(1):153-9. PubMed ID: 19013154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor.
    Ferreira D; Westman E; Eyjolfsdottir H; Almqvist P; Lind G; Linderoth B; Seiger A; Blennow K; Karami A; Darreh-Shori T; Wiberg M; Simmons A; Wahlund LO; Wahlberg L; Eriksdotter M
    J Alzheimers Dis; 2015; 43(3):1059-72. PubMed ID: 25147108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
    Tuszynski MH; Thal L; Pay M; Salmon DP; U HS; Bakay R; Patel P; Blesch A; Vahlsing HL; Ho G; Tong G; Potkin SG; Fallon J; Hansen L; Mufson EJ; Kordower JH; Gall C; Conner J
    Nat Med; 2005 May; 11(5):551-5. PubMed ID: 15852017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease.
    Mandel RJ
    Curr Opin Mol Ther; 2010 Apr; 12(2):240-7. PubMed ID: 20373268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.
    Tuszynski MH; Roberts J; Senut MC; U HS; Gage FH
    Gene Ther; 1996 Apr; 3(4):305-14. PubMed ID: 8732162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model.
    Capsoni S; Brandi R; Arisi I; D'Onofrio M; Cattaneo A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):635-47. PubMed ID: 21631402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term neuronal effects and disposition of ectopic preproNGF gene transfer into the rat septum.
    Wu K; Klein RL; Meyers CA; King MA; Hughes JA; Millard WJ; Meyer EM
    Hum Gene Ther; 2003 Oct; 14(15):1463-72. PubMed ID: 14577926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a non invasive NGF-based therapy for Alzheimer's disease.
    Covaceuszach S; Capsoni S; Ugolini G; Spirito F; Vignone D; Cattaneo A
    Curr Alzheimer Res; 2009 Apr; 6(2):158-70. PubMed ID: 19355851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and cell therapy for the nucleus basalis of Meynert with NGF in Alzheimer's disease.
    Eriksdotter M; Mitra S
    Handb Clin Neurol; 2021; 179():219-229. PubMed ID: 34225964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rAAV2-mediated NGF gene delivery in adult and aged rats.
    Wu K; Meyers CA; Guerra NK; King MA; Meyer EM
    Mol Ther; 2004 Feb; 9(2):262-9. PubMed ID: 14759810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor gene therapy in Alzheimer disease.
    Tuszynski MH
    Alzheimer Dis Assoc Disord; 2007; 21(2):179-89. PubMed ID: 17545746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor treatment in dementia.
    Jönhagen ME
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S31-8. PubMed ID: 10850728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.
    Goins WF; Yoshimura N; Phelan MW; Yokoyama T; Fraser MO; Ozawa H; Bennett N JR; de Groat WC; Glorioso JC; Chancellor MB
    J Urol; 2001 May; 165(5):1748-54. PubMed ID: 11342969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
    Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons.
    Blesch A; Conner J; Pfeifer A; Gasmi M; Ramirez A; Britton W; Alfa R; Verma I; Tuszynski MH
    Mol Ther; 2005 Jun; 11(6):916-25. PubMed ID: 15922962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.